Riata Leads Hit With 522 Request, FDA Urges X-Rays to Guide Patient Care

Devices & Diagnostics Letter
The FDA Thursday ordered St. Jude Medical to conduct three-year postmarket surveillance studies of its troubled Riata and Riata ST coronary leads to obtain data on the likelihood of premature insulation failure.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00